Incro Pharmaceuticals Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Incro Pharmaceuticals General Information

Description

Developer of bio-pharmaceutical products. The company is focused on the control of programmed necrosis for the treatment of degenerative and inflammatory diseases. It has been developing drugs that block a protein called RIP1, which is implicated when a type of brain cell called glia goes awry. Like neurons, glia are central to all manner of brain activity.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • San Diego, CA
  • United States
Primary Industry
Biotechnology
Vertical(s)
Corporate Office
  • San Diego, CA
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Incro Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Incro Pharmaceuticals‘s full profile, request access.

Request a free trial

Incro Pharmaceuticals FAQs

  • When was Incro Pharmaceuticals founded?

    Incro Pharmaceuticals was founded in 2013.

  • Where is Incro Pharmaceuticals headquartered?

    Incro Pharmaceuticals is headquartered in San Diego, CA.

  • What industry is Incro Pharmaceuticals in?

    Incro Pharmaceuticals’s primary industry is Biotechnology.

  • Is Incro Pharmaceuticals a private or public company?

    Incro Pharmaceuticals is a Private company.

  • What is the current valuation of Incro Pharmaceuticals?

    The current valuation of Incro Pharmaceuticals is .

  • What is Incro Pharmaceuticals’s current revenue?

    The current revenue for Incro Pharmaceuticals is .

  • When was Incro Pharmaceuticals acquired?

    Incro Pharmaceuticals was acquired on 25-Aug-2016.

  • Who acquired Incro Pharmaceuticals?

    Incro Pharmaceuticals was acquired by Denali Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process